Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
about
Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsThe CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries.The pharmacological approach to the elderly COPD patient.Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.Fred Neufeld and pneumococcal serotypes: foundations for the discovery of the transforming principle.
P2860
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@ast
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@en
type
label
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@ast
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@en
prefLabel
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@ast
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@en
P2860
P356
P1476
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
@en
P2093
Daniel M Musher
Iman Ridda
P2860
P304
P356
10.4066/AMJ.2012.1160
P577
2012-04-30T00:00:00Z